EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
We are looking for a new Chemistry curator to join the ChEBI team. Find out more about it here.
CHEBI:749424 - onabotulinumtoxina
| ChEBI ID | CHEBI:749424 |
| ChEBI Name | onabotulinumtoxina |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-obesity agent Any substance which is used to reduce or control weight. |
| Applications: | gastrointestinal drug A drug used for its effects on the gastrointestinal system, e.g. controlling gastric acidity, regulating gastrointestinal motility and water flow, and improving digestion. anti-ulcer drug One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract. geroprotector Any compound that supports healthy aging, slows the biological aging process, or extends lifespan. antispasmodic drug A drug that suppresses spasms. These are usually caused by smooth muscle contraction, especially in tubular organs. The effect is to prevent spasms of the stomach, intestine or urinary bladder. ophthalmology drug Any compound used for the treatment of eye conditions or eye diseases. vulnerary A drug used in treating and healing of wounds. immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. neuroprotective agent Any compound that can be used for the treatment of neurodegenerative disorders. vasodilator agent A drug used to cause dilation of the blood vessels. analgesic An agent capable of relieving pain without the loss of consciousness or without producing anaesthesia. In addition, analgesic is a role played by a compound which is exhibited by a capability to cause a reduction of pain symptoms. anti-inflammatory agent Any compound that has anti-inflammatory effects. antidepressant Antidepressants are mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. antiparkinson drug A drug used in the treatment of Parkinson's disease. antipsoriatic A drug used to treat psoriasis. anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| onabotulinumtoxina (CHEBI:749424) has role analgesic (CHEBI:35480) |
| onabotulinumtoxina (CHEBI:749424) has role anti-arrhythmia drug (CHEBI:38070) |
| onabotulinumtoxina (CHEBI:749424) has role anti-inflammatory agent (CHEBI:67079) |
| onabotulinumtoxina (CHEBI:749424) has role anti-obesity agent (CHEBI:74518) |
| onabotulinumtoxina (CHEBI:749424) has role anti-ulcer drug (CHEBI:49201) |
| onabotulinumtoxina (CHEBI:749424) has role antidepressant (CHEBI:35469) |
| onabotulinumtoxina (CHEBI:749424) has role antineoplastic agent (CHEBI:35610) |
| onabotulinumtoxina (CHEBI:749424) has role antiparkinson drug (CHEBI:48407) |
| onabotulinumtoxina (CHEBI:749424) has role antipsoriatic (CHEBI:50748) |
| onabotulinumtoxina (CHEBI:749424) has role antispasmodic drug (CHEBI:53784) |
| onabotulinumtoxina (CHEBI:749424) has role gastrointestinal drug (CHEBI:55324) |
| onabotulinumtoxina (CHEBI:749424) has role geroprotector (CHEBI:176497) |
| onabotulinumtoxina (CHEBI:749424) has role immunosuppressive agent (CHEBI:35705) |
| onabotulinumtoxina (CHEBI:749424) has role neuroprotective agent (CHEBI:63726) |
| onabotulinumtoxina (CHEBI:749424) has role ophthalmology drug (CHEBI:66981) |
| onabotulinumtoxina (CHEBI:749424) has role vasodilator agent (CHEBI:35620) |
| onabotulinumtoxina (CHEBI:749424) has role vulnerary (CHEBI:73336) |
| onabotulinumtoxina (CHEBI:749424) is a organic molecular entity (CHEBI:50860) |
| Synonyms | Source |
|---|---|
| Bontoxilysin | ChEMBL |
| Botulin | ChEMBL |
| Botulinum neurotoxin | ChEMBL |
| Botulinum toxin | ChEMBL |
| Onabotulinumtoxina | ChEMBL |
| RTI-150 | ChEMBL |
| Brand Name | Source |
|---|---|
| Botox/botox cosmetic | ChEMBL |